Kumar, S. K., Hayman, S. R., Buadi, F. K., Roy, V., Lacy, M. Q., Gertz, M. A., . . . Dispenzieri, A. (2012). Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: Long-term results from a phase 2 trial. American Society of Hematology.
শিকাগো স্টাইলে সাইটেশনKumar, Shaji K., et al. Lenalidomide, Cyclophosphamide, and Dexamethasone (CRd) for Light-chain Amyloidosis: Long-term Results From a Phase 2 Trial. American Society of Hematology, 2012.
এমএলএ সাইটেশনKumar, Shaji K., et al. Lenalidomide, Cyclophosphamide, and Dexamethasone (CRd) for Light-chain Amyloidosis: Long-term Results From a Phase 2 Trial. American Society of Hematology, 2012.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.